44.47Average Price Target
The highest estimate is 56.75.
From 4 ratings within the last 6 months. This is not an investment recommendation.
This list is based on the watchlists of people on Stock Events who follow BIOA.TO. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.
Show more...
FAQ
What is BioAmber stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Toronto Exchange exchange BioAmber stocks are traded under the ticker BIOA.TO.
When is the next BioAmber earnings date?▼
BioAmber is going to release the next earnings report on November 05, 2026.
What were BioAmber earnings last quarter?▼
BIOA.TO earnings for the last quarter are -0.81 CAD per share, whereas the estimation was -0.85 CAD resulting in a +4.5% surprise. The estimated earnings for the next quarter are N/A CAD per share.
What is BioAmber revenue for the last year?▼
BioAmber revenue for the last year amounts to 12.45M CAD.
What is BioAmber net income for the last year?▼
BIOA.TO net income for the last year is -111.63M CAD.
How many employees does BioAmber have?▼
As of September 05, 2026, the company has 62 employees.
In which sector is BioAmber located?▼
BioAmber operates in the Health & Wellness sector.
When did BioAmber complete a stock split?▼
BioAmber has not had any recent stock splits.
Where is BioAmber headquartered?▼
BioAmber is headquartered in EMERYVILLE, United States.